Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

This early-phase study is testing whether a new experimental drug called amisodin is safe and well-tolerated in healthy adults. Even though it's titled around ALS (amyotrophic lateral sclerosis, a progressive neurological disease), this phase is enrolling healthy volunteers to understand how the drug behaves in the body before testing it in patients. **You may be eligible if...** - You are a healthy adult between 18 and 55 years old - If you are female, you must be past menopause or have had a sterilization procedure (the study excludes women of childbearing potential) - You are not taking any regular medications - Your overall health is good based on screening tests **You may NOT be eligible if...** - You are a woman of childbearing potential (able to become pregnant) - You have any significant medical conditions, abnormal lab values, or history of serious illness - You smoke heavily or use drugs - You have participated in another drug trial recently Talk to your doctor to see if this trial is right for you.